HIV Drug Resistance Assays

About Aldatu Biosciences

Aldatu Biosciences is a private, US-based biotech founded in 2014, specializing in adaptive PCR diagnostics for infectious diseases. Its proprietary PANDAA technology platform addresses a critical challenge in molecular diagnostics by allowing real-time PCR assays to remain effective against evolving viral variants, thereby ensuring long-term assay integrity. The company's pipeline targets high-need areas including HIV drug resistance testing and pandemic preparedness for pathogens like SARS-CoV-2, Lassa virus, Ebola, and Crimean-Congo Hemorrhagic Fever virus. Operating as a public benefit corporation, Aldatu leverages grant funding, such as NIH SBIR awards, to advance its platform and expand its diagnostic product portfolio.

Therapeutic Areas